EMSIVEL
Live / Registered — Registered (as of 31 May 2022)
What this means for you
Registered since 31 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79328206
- Registration number
- 6741816
- Mark type
- Stylized text
- Filed
- 25 Oct 2021
- Published for opposition
- 15 Mar 2022
- Registered
- 31 May 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma, excluding mineral salts or products containing mineral salts and excluding products for the prevention and treatment or respiratory disorders and diseases
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 19 Sept 2022 — NOTIFICATION PROCESSED BY IB
- 25 Aug 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Aug 2022 — FINAL DISPOSITION PROCESSED
- 30 Jun 2022 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 31 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 21 Mar 2022 — NOTIFICATION PROCESSED BY IB
- 15 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Mar 2022 — PUBLISHED FOR OPPOSITION
- 23 Feb 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Feb 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 23 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2022 — ASSIGNED TO EXAMINER
- 26 Jan 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED